India sees insignificant revision to price ceiling in 2024
India’s share of the US generic market is growing rapidly, and the number of companies and manufacturing facilities supplying to the U.S. market is growing fast. The focus on growing regulatory requirements, improved healthcare infrastructure, and surge in research and development spend bodes well for the pharma industry. The Indian government believes that the prices …
India sees insignificant revision to price ceiling in 2024 Bővebben »